# Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations

> **NCT06912490** · NA · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 78 (estimated)

## Conditions studied

- Kidney Diseases

## Interventions

- **OTHER:** Amniotic Fluid Proteomic Analysis Using Capillary Electrophoresis-Mass Spectrometry (CE-MS)

## Key facts

- **NCT ID:** NCT06912490
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-18
- **Primary completion:** 2029-12-20
- **Final completion:** 2029-12-20
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06912490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06912490, "Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06912490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*